Patient Characteristics and Incidence of Genetic Markers in CD34+ Cells
| Patient . | Age/Sex . | Time of dx . | Binet . | Treatment . | Genetic Marker . | Source . | CD34+/38+ . | Abnormal Karyotype . | CD34+/38− . | Abnormal Karyotype . | Sort Unpurity . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | . | . | . | . | . | (n) . | (%) . | (n) . | (%) . | (%) . |
| KU | 41/F | 8/95 | A | — | +12 | BM | 93 | 34 | 164 | 13 | 2 |
| WM | 72/F | 10/95 | C | — | +12 | BM | 53 | 62 | 14 | 42 | 2 |
| HD | 64/M | 1992 | C | COP/CHOP | +12 | BM | 9 | 48 | 5 | 80 | 2 |
| KC | 48/F | 1993 | A | — | +12 | PB | 42 | 0 | 40 | 0 | 2 |
| BE | 71/F | 1987 | C | F, C/P | +12 | PB | 101 | 6.3 | ND | ND | 15 |
| SH | 64/M | 12/94 | B | C/P | +12 | PB | 500 | 1 | 24 | 15 | 15 |
| BR | 57/M | 11/95 | A | — | +12 | BM | 41 | 0 | 32 | 0 | 1 |
| GL | 52/M | 3/96 | B | F | −Rb | PB | 100 | 2 | 45 | 0 | 3 |
| HM | 74/F | 3/96 | A | — | −Rb | PB | 20 | 10 | 4 | 0 | 3 |
| Patient . | Age/Sex . | Time of dx . | Binet . | Treatment . | Genetic Marker . | Source . | CD34+/38+ . | Abnormal Karyotype . | CD34+/38− . | Abnormal Karyotype . | Sort Unpurity . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | . | . | . | . | . | (n) . | (%) . | (n) . | (%) . | (%) . |
| KU | 41/F | 8/95 | A | — | +12 | BM | 93 | 34 | 164 | 13 | 2 |
| WM | 72/F | 10/95 | C | — | +12 | BM | 53 | 62 | 14 | 42 | 2 |
| HD | 64/M | 1992 | C | COP/CHOP | +12 | BM | 9 | 48 | 5 | 80 | 2 |
| KC | 48/F | 1993 | A | — | +12 | PB | 42 | 0 | 40 | 0 | 2 |
| BE | 71/F | 1987 | C | F, C/P | +12 | PB | 101 | 6.3 | ND | ND | 15 |
| SH | 64/M | 12/94 | B | C/P | +12 | PB | 500 | 1 | 24 | 15 | 15 |
| BR | 57/M | 11/95 | A | — | +12 | BM | 41 | 0 | 32 | 0 | 1 |
| GL | 52/M | 3/96 | B | F | −Rb | PB | 100 | 2 | 45 | 0 | 3 |
| HM | 74/F | 3/96 | A | — | −Rb | PB | 20 | 10 | 4 | 0 | 3 |
Abbreviations: C/P, chlorambucil/prednison; F, fludarabin; ND, not determined; BM, bone marrow; PB, peripheral blood.